Kate Bailey

QIAGEN GeneReader NGS System to relaunch in U.S. market

New improved chemistry for first Sample to Insight next-generation sequencing solution to be made available to first customers in December 2016 Charlotte, North Carolina, and Hilden, Germany, November 9, 2016 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the validation of new and improved sequencing  chemistry for its GeneReader NGS System, the… Read article →

QIAGEN at AMP 2016

Join us at AMP for solutions, from trusted molecular detection to clinical decision support The AMP 2016 Annual Meeting is just around the corner, and we’re excited to see you there at the Convention Center in Charlotte, NC, Nov 10—12! Stop by our booth! Come to booth #1119 to explore our products and speak with our… Read article →

QIAGEN launches novel integrated system for collection, stabilization, transport, storage and isolation of circulating cell-free DNA

Hilden, Germany, and Germantown, Maryland, July 27, 2016 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the new PAXgene® Blood ccfDNA Tube* for venous whole blood collection and room temperature stabilization of in-vivo circulating cell-free DNA (ccfDNA) profiles. Together with the QIAamp Circulating Nucleic Acid Kit – the gold… Read article →

Load More Posts